A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathwaySae‐Bom Yoon, Heeyeong Cho|Acta Pharmaceutica Sinica B|2022Cited by 40